Larazotide is a peptide designed specifically to address intestinal permeability, commonly known as leaky gut. This condition occurs when the tight junctions in the intestinal lining loosen, allowing toxins, pathogens, and undigested food particles to escape into the bloodstream
Frontiers in Pharmacology, 12, 627533
This guide examines what makes the BPC-157 peptide structurally and mechanistically unique, what the published literature actually shows about its activity, and how researchers approach working with it in a laboratory setting
Human clinical evidence for GHK-Cu is mostly small, industry-funded topical skin trials
For systemic peptides like MOTS-c or SS-31 , the injection site matters less because the peptide enters systemic circulation regardless of where it is administered